Showing results (351-360 of 401) with videos related to

Sort By:
Pageof 41
Nature Methods|March 2, 2021
Dual DNA and protein tagging of open chromatin unveils dynamics of epigenomic landscapes in leukemiaJonathan D Lee, Joao A Paulo, Ryan R Posey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthDharmendra Gurve, Andrew Peter Centen, Penelope J Slack, et al.
Cell Reports|December 4, 2012
FGF regulates TGF-β signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expressionPei-Yu Chen, Lingfeng Qin, Carmen Barnes, et al.
Journal of Medicinal Chemistry|September 26, 2022
Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic DiseaseFredrik R Zetterberg, Alison MacKinnon, Thomas Brimert, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthCaroline S Duchaine, Manuel Montero-Odasso, Haakon B Nygaard, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2017
Identification of selective 8-(piperidin-4-yloxy)quinoline sulfone and sulfonamide histamine H1 receptor antagonists for use in allergic rhinitisPanayiotis A Procopiou, Alison J Ford, Paul M Gore, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 19, 2025
Risk factor profiles and cognitive function in older adults: the Brain Health Support Program StudyCaroline S Duchaine, Manuel Montero-Odasso, Haakon B Nygaard, et al.
Frontiers in Pharmacology|August 25, 2022
Galectin-3 inhibitor GB0139 protects against acute lung injury by inhibiting neutrophil recruitment and activationDuncan C Humphries, Ross Mills, Cecilia Boz, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
Design of Phthalazinone Amide Histamine H1 Receptor Antagonists for Use in RhinitisPanayiotis A Procopiou, Alison J Ford, Paul M Gore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2020
Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In VivoEleni Anastasiadou, Anita G Seto, Xuan Beatty, et al.
Pageof 41